Suchergebnisse - "Pearson, Steven D"

PubPharm (253)

81

Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma

enthalten in: JAMA network open | 2019

von Whittington, M. | McQueen, R. | Ollendorf, D. | +5

82

The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin Amyloidosis

enthalten in: Journal of managed care & specialty pharmacy | 2019

von Mickle, K. | Lasser, K. | Hoch, J. | +3

83

Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis

enthalten in: Journal of managed care & specialty pharmacy | 2018

von Hendrix, N. | Ollendorf, D. | Chapman, R. | +6

84

Real-world evidence for coverage decisions : opportunities and challenges

enthalten in: Journal of comparative effectiveness research | 2018

von Hampson, G. | Towse, A. | Dreitlein, W. | +2

85

Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia

enthalten in: JAMA pediatrics | 2018

von Whittington, M. | McQueen, R. | Ollendorf, D. | +5

CommentIn: JAMA Pediatr. 2018 Dec 1;172(12):1123-1124. - PMID 30304346

86

A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions

enthalten in: Journal of comparative effectiveness research | 2018

von Pearson, S. | Dreitlein, W. | Towse, A. | +2

87

Comparative effectiveness of targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis : A systematic review and network meta-analysis

enthalten in: Journal of the American Academy of Dermatology | 2018

von Loos, A. | Liu, S. | Segel, C. | +3

88

The Authors Respond : Reframing the Value of Treatments for Relapsed Refractory Multiple Myeloma

enthalten in: Journal of managed care & specialty pharmacy | 2018

von Carlson, J. | Guzauskas, G. | Chapman, R. | +6

CommentOn: J Manag Care Spec Pharm. 2018 Jan;24(1):29-38. - PMID 29290170

89

Value-Based Pricing and Patient Access for Specialty Drugs

enthalten in: JAMA | 2018

von Robinson, J. | Howell, S. | Pearson, S.

90

Evaluating and Valuing Drugs for Rare Conditions : No Easy Answers

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2018

von Ollendorf, D. | Chapman, R. | Pearson, S.